174 related articles for article (PubMed ID: 2434191)
1. Monoaminergic innervation of the frontal and temporal lobes in Alzheimer's disease.
Palmer AM; Wilcock GK; Esiri MM; Francis PT; Bowen DM
Brain Res; 1987 Jan; 401(2):231-8. PubMed ID: 2434191
[TBL] [Abstract][Full Text] [Related]
2. Catecholaminergic neurones assessed ante-mortem in Alzheimer's disease.
Palmer AM; Francis PT; Bowen DM; Benton JS; Neary D; Mann DM; Snowden JS
Brain Res; 1987 Jun; 414(2):365-75. PubMed ID: 3620938
[TBL] [Abstract][Full Text] [Related]
3. Alzheimer's disease: monoamines and spiperone binding reduced in nucleus basalis.
Sparks DL; Markesbery WR; Slevin JT
Ann Neurol; 1986 Jun; 19(6):602-4. PubMed ID: 2425718
[TBL] [Abstract][Full Text] [Related]
4. Monoamine neurotransmitters and their metabolites in brain regions in Alzheimer's disease: a postmortem study.
Nazarali AJ; Reynolds GP
Cell Mol Neurobiol; 1992 Dec; 12(6):581-7. PubMed ID: 1283363
[TBL] [Abstract][Full Text] [Related]
5. Regional changes in monoamines and metabolites following defensive aggression in the rat.
Kantak KM; Hegstrand LR; Eichelman B
Brain Res Bull; 1984 Mar; 12(3):227-32. PubMed ID: 6202379
[TBL] [Abstract][Full Text] [Related]
6. Seasonal and circadian monoamine variations in human brains examined post mortem.
Carlsson A; Svennerholm L; Winblad B
Acta Psychiatr Scand Suppl; 1980; 280():75-85. PubMed ID: 6157305
[No Abstract] [Full Text] [Related]
7. Reverse-phase high-performance liquid chromatographic separation and electrochemical detection of norepinephrine, dopamine, serotonin, and related major metabolites.
Kempf E; Mandel P
Anal Biochem; 1981 Apr; 112(2):223-31. PubMed ID: 6167177
[No Abstract] [Full Text] [Related]
8. Biogenic amines distribution in the brain of nervous and normal pointer dogs. A genetic animal model of anxiety.
Gurguis GN; Klein E; Mefford IN; Uhde TW
Neuropsychopharmacology; 1990 Aug; 3(4):297-303. PubMed ID: 1698064
[TBL] [Abstract][Full Text] [Related]
9. Postmortem changes in catecholamines, indoleamines, and their metabolites in rat brain regions: prevention with 10-kW microwave irradiation.
Ikarashi Y; Sasahara T; Maruyama Y
J Neurochem; 1985 Sep; 45(3):935-9. PubMed ID: 2411860
[TBL] [Abstract][Full Text] [Related]
10. Determination of conjugated monoamine metabolites in brain tissue.
Swahn CG; Wiesel FA
J Neural Transm; 1976; 39(4):281-90. PubMed ID: 993790
[TBL] [Abstract][Full Text] [Related]
11. Regional distribution of monoamines and their metabolites in the human brain.
Mackay AV; Yates CM; Wright A; Hamilton P; Davies P
J Neurochem; 1978 Apr; 30(4):841-8. PubMed ID: 650225
[No Abstract] [Full Text] [Related]
12. Determination of dopamine, norepinephrine, serotonin and their major metabolic products in rat brain by reverse-phase ion-pair high performance liquid chromatography with electrochemical detection.
Kotake C; Heffner T; Vosmer G; Seiden L
Pharmacol Biochem Behav; 1985 Jan; 22(1):85-9. PubMed ID: 2579406
[TBL] [Abstract][Full Text] [Related]
13. Changes in the serotonergic, noradrenergic and dopaminergic levels in the brain of scrapie-infected rats.
Bassant MH; Picard M; Olichon D; Cathala F; Court L
Brain Res; 1986 Mar; 367(1-2):360-3. PubMed ID: 2421836
[TBL] [Abstract][Full Text] [Related]
14. Biogenic amines and metabolites in spinal cord of patients with Parkinson's disease and amyotrophic lateral sclerosis.
Sofic E; Riederer P; Gsell W; Gavranovic M; Schmidtke A; Jellinger K
J Neural Transm Park Dis Dement Sect; 1991; 3(2):133-42. PubMed ID: 1716905
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous determination of norepinephrine, dopamine, 5-hydroxytryptamine and their main metabolites in rat brain using high-performance liquid chromatography with electrochemical detection. Enzymatic hydrolysis of metabolites prior to chromatography.
Warnhoff M
J Chromatogr; 1984 May; 307(2):271-81. PubMed ID: 6203923
[TBL] [Abstract][Full Text] [Related]
16. Increased activity of surviving locus ceruleus neurons in Alzheimer's disease.
Hoogendijk WJ; Feenstra MG; Botterblom MH; Gilhuis J; Sommer IE; Kamphorst W; Eikelenboom P; Swaab DF
Ann Neurol; 1999 Jan; 45(1):82-91. PubMed ID: 9894881
[TBL] [Abstract][Full Text] [Related]
17. Neurochemical studies of early-onset Alzheimer's disease. Possible influence on treatment.
Francis PT; Palmer AM; Sims NR; Bowen DM; Davison AN; Esiri MM; Neary D; Snowden JS; Wilcock GK
N Engl J Med; 1985 Jul; 313(1):7-11. PubMed ID: 2582256
[TBL] [Abstract][Full Text] [Related]
18. Increased serotoninergic and noradrenergic activity in hepatic encephalopathy in rats with thioacetamide-induced acute liver failure.
Yurdaydin C; Hörtnagl H; Steindl P; Zimmermann C; Pifl C; Singer EA; Roth E; Ferenci P
Hepatology; 1990 Oct; 12(4 Pt 1):695-700. PubMed ID: 1698704
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous determination of dopamine, serotonin, 3,4-dihydroxyphenyl-acetic acid, homovanillic acid, 3-methoxytyramine and 5-hydroxyindole-3-acetic acid by high performance liquid chromatography with electrochemical detection.
Yokoo H; Kojima H; Yamada S; Tsutsumi T; Anno N; Anraku S; Nishi S; Inanaga K
Kurume Med J; 1985; 32(1):75-80. PubMed ID: 2418259
[No Abstract] [Full Text] [Related]
20. Alcohol preference and regional brain monoamine contents of N/Nih heterogeneous stock rats.
Murphy JM; McBride WJ; Lumeng L; Li TK
Alcohol Drug Res; 1987; 7(1):33-9. PubMed ID: 2431698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
